BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Business

  Wright Medical Group, Inc. Appoints Kevin D. Cordell As President, U.S. Extremities

  September 16, 2014

   · 

  1 min read
• Drug Development

  Agile Therapeutics, Inc. Initiates Phase 3 SECURE Study For Twirla™

  September 16, 2014

   · 

  5 min read
• Drug Development

  Relypsa, Inc. Announces New Analysis Of Phase 3 Data Demonstrating Patiromer’s Ability To Rapidly Correct, And Prevent Recurrence Of, Hyperkalemia In Heart Failure And Non-Heart Failure Patients

  September 16, 2014

   · 

  7 min read
• Pharm Country

  ReWalk To Ring The NASDAQ Stock Market Opening Bell

  September 16, 2014

   · 

  2 min read
• Drug Development

  Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis

  September 16, 2014

   · 

  18 min read
• Pharm Country

  NMS Labs Announces Crucial New Tool For Impaired Driving Investigation

  September 16, 2014

   · 

  1 min read
• BioMidwest

  Cancer Treatment Centers Of America Receives Angel Award For Outstanding Medical Service From Imerman Angels

  September 16, 2014

   · 

  2 min read
• Business

  Ortho Kinematics Enters Agreement With Medtronic, Inc. For Promotion Of VMA

  September 16, 2014

   · 

  1 min read
• BioForest

  CeloNova BioSciences Release: First-In-Man Study Of The COBRA PzF™ Coronary Stent Shows Promising Results Highlighted By Short, 30-Day Dual-Antiplatelet Therapy And Low, 3% TLR Rate

  September 16, 2014

   · 

  1 min read
• Policy

  Salix Pharmaceuticals, Ltd. Release: UCERIS® (budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA

  September 16, 2014

   · 

  1 min read